Elixxer Ltd (ELXR) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.024x

Based on the latest financial reports, Elixxer Ltd (ELXR) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-367.24K ≈ $-265.66K USD) by net assets (CA$-15.05 Million ≈ $-10.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ELXR company net worth for the company's overall valuation and market capitalisation.

Elixxer Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Elixxer Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Elixxer Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Elixxer Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Elixxer Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Vaxil Bio Ltd V:VXL	-0.042x
Europa Oil & Gas Holdings LSE:EOG	-0.080x
Multistack International Ltd AU:MSI	-0.834x
Hemogenyx Pharmaceuticals PLC LSE:HEMO	3.264x
Altair Resources Inc V:AVX	0.002x
Annum Bhd KLSE:5082	0.001x
Hawkeye Gold and Diamond Inc V:HAWK	0.031x
Lytus Technologies Holdings PTV. Ltd. Common Shares NASDAQ:LYT	0.005x

Annual Cash Flow Conversion Efficiency for Elixxer Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Elixxer Ltd from 2017 to 2024. View Elixxer Ltd (ELXR) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-13.09 Million ≈ $-9.47 Million	CA$0.00 ≈ $0.00	0.000x	--
2023-12-31	CA$-9.60 Million ≈ $-6.94 Million	CA$-2.40 Million ≈ $-1.74 Million	0.250x	-53.81%
2022-12-31	CA$-5.58 Million ≈ $-4.04 Million	CA$-3.02 Million ≈ $-2.19 Million	0.541x	+212.79%
2021-12-31	CA$8.38 Million ≈ $6.06 Million	CA$-4.02 Million ≈ $-2.91 Million	-0.480x	+24.26%
2020-12-31	CA$4.76 Million ≈ $3.44 Million	CA$-3.01 Million ≈ $-2.18 Million	-0.633x	-148.31%
2018-12-31	CA$17.67 Million ≈ $12.79 Million	CA$-4.51 Million ≈ $-3.26 Million	-0.255x	+84.87%
2017-12-31	CA$1.58 Million ≈ $1.14 Million	CA$-2.66 Million ≈ $-1.92 Million	-1.685x	--

About Elixxer Ltd

V:ELXR Canada Drug Manufacturers - Specialty & Generic

Market Cap

$287.08K

CA$396.86K CAD

Market Cap Rank

#31244 Global

#1668 in Canada

Share Price

CA$0.04

Change (1 day)

+0.00%

52-Week Range

CA$0.03 - CA$1.15

All Time High

CA$99.00